Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Current Leases (2019 - 2024)

BioRestorative Therapies (BRTX) has disclosed Current Leases for 6 consecutive years, with $42414.0 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Current Leases fell 72.87% year-over-year to $42414.0, compared with a TTM value of $42414.0 through Sep 2024, down 72.87%, and an annual FY2023 reading of $162317.0, up 16.5% over the prior year.
  • Current Leases was $42414.0 for Q3 2024 at BioRestorative Therapies, down from $83580.0 in the prior quarter.
  • Across five years, Current Leases topped out at $162317.0 in Q4 2023 and bottomed at $42414.0 in Q3 2024.
  • Average Current Leases over 5 years is $119796.8, with a median of $123536.0 recorded in 2024.
  • The sharpest move saw Current Leases skyrocketed 85.31% in 2020, then tumbled 72.87% in 2024.
  • Year by year, Current Leases stood at $158371.0 in 2020, then fell by 24.83% to $119055.0 in 2021, then increased by 17.03% to $139328.0 in 2022, then increased by 16.5% to $162317.0 in 2023, then crashed by 73.87% to $42414.0 in 2024.
  • Business Quant data shows Current Leases for BRTX at $42414.0 in Q3 2024, $83580.0 in Q2 2024, and $123536.0 in Q1 2024.